Trumps Potential Absence at Sons Wedding Highlights Geopolitical Pressures on Market Sentiment PutinXi Talks Expected to Revive Stalled Power of Siberia 2 Gas Pipeline Amid IranLed Energy Market Turmoil JPMorgan Chase Declares Quarterly Dividend of 150 per Share Beyond Inc to Acquire Buy Buy Baby Brand Rights Reuniting with Bed Bath Beyond SP 500 and Nasdaq Scale New Peaks as AI Momentum Drives Tech Rally Micron Enters TrillionDollar Club WSJs Heard on the Street Unveils Eighth Annual StockPicking Contest Selections AG Q1 2026 Earnings Silver Miner Misses EPS Estimates as Costs Weigh on Profitability KKR Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower New Mountain Finance Corporation NMFC Q1 2026 Earnings Slight EPS Miss Weighs on Shares MH Q1 2026 Earnings Massive EPS Beat Fails to Lift Stock Via Transportation Inc VIA Q1 2026 Earnings EPS Beat Exceeds Estimates by 1319 WHLR Q2 2024 Earnings Strong Reported EPS Lifts Stock Slightly Amid Sparse Disclosure AGCO Corporation AGCO Holds Steady Near Key Support After Minor Decline DarioHealth Corp DRIO Rallies 411 Testing Key Resistance at 825 GEN Restaurant Group GENK Faces Selling Pressure Approaches Key Support Level Xtant Medical Holdings Holds Near Key Resistance Level After Modest Gain Truist Financial TFC Holds Near Support After Modest Decline Amid Sector Rotation SpaceX IPO Opens to Retail Investors Through Major Brokerage Platforms Galiano Gold Inc GAU Q1 2026 Earnings EPS Misses Estimates but Stock Rises 273 NIP Group Inc NIPG Slides 534 Testing Key Support at 040 T Stamp Inc Q1 2026 Earnings EPS Misses Estimates as Revenue Details Remain Unavailable KDP Q1 2026 Earnings Earnings Beat Drives Modest Stock Uptick Amid Revenue Disclosures Uncertainty QFIN Q4 2025 Earnings EPS Misses Estimates Shares Slide 518 CRVS Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Clinical Development IONS Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Sentiment AstroNova Inc Q1 2026 Earnings A Loss Per Share Amid Quiet Revenue Disclosure Minerva Neurosciences Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Faces Challenges